Figure 1. Screening of tumor prognosis-related factors and construction of risk assessment models. (A) Heatmap screening for differentially expressed genes. (B) Results of GO and KEGG enrichment analysis (p < 0.05). (C, D) Screening of tumor prognosis-related genes by LASSO regression analysis. (E) Reliability of risk regression models verified by survival and ROC curves of FKBP11 and BINP3. *P < 0.05, **P < 0.01, and ***p < 0.001.